Skip to main content

Advertisement

Log in

Increased NDRG1 Expression is Associated with Advanced T Stages and Poor Vascularization in Non-small Cell Lung Cancer

  • Research
  • Published:
Pathology & Oncology Research

Abstract

N-myc downstream regulated gene 1 (NDRG1) is a member of the N-myc downstream regulated gene family which belongs to the alpha/beta hydrolase superfamily. Earlier studies have shown its association with inhibition of tumor metastasis. However, its function in malignant tumors is not fully enunciated. Recently there was increasing evidence that NDRG1 is involved in stress responses. In the current study, we examined the expression of NDRG1 and its correlation with clinicopathological factors and microvessel density (MVD) in non-small cell lung cancer (NSCLC) using immunohistochemistry (IHC). NDRG1 expression in NSCLC (71/115, 61.7%) was higher than that in normal lung tissues (32/115, 27.8%) (p < 0.05). NDRG1 expression in NSCLC cells was found in cytoplasm (63/115, 54.8%), nuclear (24/115, 20.9%) and cell membrane (13/115, 11.3%). NDRG1 expression in NSCLC with advanced T stages (T2-4) (63/84, 75.0%) was significantly higher than that with T1 stage (8/31, 25.8%) (P < 0.05). No other clinicopathological factors including lymph node metastasis were found to be associated with NDRG1 expression (p > 0.05). Moreover increased NDRG1 expression was associated with lower MVD in NSCLC (P < 0.05). MVD in adenocarcinoma (33.4 ± 8.4/HP) was significantly higher than that in squamous cell carcinoma (SCC) (19.3 ± 8.1/HP) (P < 0.05). No other clinicopathological factors were associated with MVD in NSCLC (p > 0.05). The present findings indicate an increase of NDRG1 expression with the progress of tumour extent which may be due to unbalanced tumor oxygenation on account of poor vascularization in NSCLC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Abbreviations

NDRG1:

N-myc downstream regulated gene 1

MVD:

Microvessel density

NSCLC:

Non-small cell lung cancer

IHC:

Immunohistochemistry

UICC:

International Union Against Cancer

WHO:

World Health Organization

SCC:

Squamous cell carcinoma

References

  1. Lachat P, Shaw P, Gebhard S et al (2002) Expression of NDRG1, a differentiation-related gene, in human tissues. Histochem Cell Biol 118:399–408

    Article  PubMed  CAS  Google Scholar 

  2. Taketomi Y, Sugiki T, Saito T et al (2003) Identification of NDRG1 as an early inducible gene during in vitro maturation of cultured mast cells. Biochem Biophys Res Commun 306:339–346

    Article  PubMed  CAS  Google Scholar 

  3. Wakisaka Y, Furuta A, Masuda K et al (2003) Cellular distribution of NDRG1 protein in the rat kidney and brain during normal postnatal development. J Histochem Cytochem 51:1515–1525

    Article  PubMed  CAS  Google Scholar 

  4. Rutherford MN, Bayly GR, Matthews BP et al (2001) The leukemogenic transcription factor E2a-Pbx1 induces expression of the putative N-myc and p53 target gene NDRG1 in Ba/F3 cells. Leukemia 15:362–370

    Article  PubMed  CAS  Google Scholar 

  5. Angst E, Sibold S, Tiffon C et al (2006) Cellular differentiation determines the expression of the hypoxia-inducible protein NDRG1 in pancreatic cancer. Br J Cancer 95:307–313

    Article  PubMed  CAS  Google Scholar 

  6. Echaniz-Laguna A, Degos B, Bonnet C et al (2007) NDRG1-linked Charcot-Marie-Tooth disease (CMT4D) with central nervous system involvement. Neuromuscul Disord 17:163–168

    Article  PubMed  Google Scholar 

  7. Zhou D, Salnikow K, Costa M (1998) Cap43, a novel gene specially induced by Ni2+ compounds. Cancer Res 58:2182–2189

    PubMed  CAS  Google Scholar 

  8. Salnikow K, Blagosklonny MV, Ryan H et al (2000) Carcinogenic nickel induces genes involved with hypoxic stress. Cancer Res 60:38–41

    PubMed  CAS  Google Scholar 

  9. Hakan C (2004) Hypoxia upregulates the expression of the NDRG1 gene leading to its overexpression in various human cancers. BMC Genet 5:27

    Google Scholar 

  10. Joseph TC, Hung-Ming W, Ku-Wei C et al (2005) Identification of differentially expressed genes in oral squamous cell carcinoma (OSCC): Overexpression of NPM, CDK1 and NDRG1 and underexpression of CHES1. Int J Cancer 114:942–949

    Article  Google Scholar 

  11. Sonja S, Vincent R, Adrian K et al (2007) Hypoxia increases cytoplasmic expression of NDRG1, but is insufficient for its membrane localization in human hepatocellular carcinoma. FEBS Lett 581:989–994

    Article  Google Scholar 

  12. Mei-Sze C, Hongbo S, Siu TC et al (2007) Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma. Mod Pathol 20:76–83

    Article  Google Scholar 

  13. Sobin DHWC (2002) International Union Against Cancer (UICC): TNM Classification of Malignant Tumors, 6. Wiley-Liss, New York

    Google Scholar 

  14. Travis WDBE, Muller-Hermelink HK, Harris CC (2004) World health organization classification of tumors: pathology and genetics of tumors of the lung, pleura, thymus and heart. IARC, Lyon

    Google Scholar 

  15. Weidner N, Semple JP, Welch WR et al (1991) Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 324:1–8

    Article  PubMed  CAS  Google Scholar 

  16. Bandyopadhyay S, Pai SK, Gross SC et al (2003) The Drg-1 gene suppresses tumor metastasis in prostate cancer. Cancer Res 63:1731–1736

    PubMed  CAS  Google Scholar 

  17. Bandyopadhyay S, Pai SK, Hirota S et al (2004) Role of the putative tumor metastasis suppressor gene Drg-1 in breast cancer progression. Oncogene 23:5675–5681

    Article  PubMed  CAS  Google Scholar 

  18. Ulrix W, Swinnen JV, Heyns W et al (1999) The differentiation-related gene 1, Drg1, is markedly upregulated by androgens in LNCaP prostatic adenocarcinoma cells. FEBS Lett 455:23–26

    Article  PubMed  CAS  Google Scholar 

  19. Kokame K, Kato H, Miyata T (1996) Homocysteine-respondent genes in vascular endothelial cells identified by differential display analysis. GRP78/BiP and novel genes. J Biol Chem 271:29659–29665

    Article  PubMed  CAS  Google Scholar 

  20. Shin N, Kimio U, Naotake T et al (2008) Cap43/NDRG1/Drg-1 is a molecular target for angiogenesis and a prognostic indicator in cervical adenocarcinoma. Cancer Letters 264:36–43

    Article  Google Scholar 

  21. Maruyama Y, Ono M, Kawahara A et al (2006) Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis. Cancer Res 66:6233–6242

    Article  PubMed  CAS  Google Scholar 

  22. Guan RJ, Ford HL, Fu Y et al (2000) Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer. Cancer Res 60:749–755

    PubMed  CAS  Google Scholar 

  23. Macchiarini P, Fontanini G, Hardin MJ et al (1992) Relation of neovascularisation to metastasis of non-small cell lung cancer. Lancet 340:145–146

    Article  PubMed  CAS  Google Scholar 

  24. Fontanini G, Bigini D, Vignati S et al (1995) Microvessel count predicts metastatic disease and survival in non-small cell lung cancer. J Pathol 177:57–63

    Article  PubMed  CAS  Google Scholar 

  25. Maeda K, Chung YS, Takatsuka S et al (1995) Tumor angiogenesis as a predictor of recurrence in gastric carcinoma. J Clin Oncol 13:477–481

    PubMed  CAS  Google Scholar 

  26. Yamazaki K, Abe S, Takekawa H et al (1994) Tumor angiogenesis in human lung adenocarcinoma. Cancer 74:2245–2250

    Article  PubMed  CAS  Google Scholar 

  27. Anne E, Sebastian K, Valentin G et al (2000) Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies. Cancer Res 60:1388–1393

    Google Scholar 

  28. Fumihiro T, Hiroki O, Kazumasa T et al (2003) Glomeruloid microvascular proliferation is superior to intratumoral microvessel density as a prognostic marker in non-small cell lung cancer. Cancer Res 63:6791–6794

    Google Scholar 

  29. Guo J, Higashi K, Ueda Y et al (2006) Microvessel density: correlation with 18F-FDG uptake and prognostic impact in lung adenocarcinomas. J Nucl Med 47:419–425

    PubMed  CAS  Google Scholar 

  30. Trivella M, Pezzella F, Pastorino U et al (2007) Microvessel density as a prognostic factor in non-small-cell lung carcinoma: a meta-analysis of individual patient data. Lancet Oncol 8:488–499

    Article  PubMed  Google Scholar 

  31. Sardari NP, Stessels F, Pezzella F et al (2003) Growth index is independent of microvessel density in non-small cell lung carcinomas. Hum Pathol 34:959–960

    Google Scholar 

  32. Zheng Y, Wang LS, Xia L et al (2009) NDRG1 is down-regulated in the early apoptotic event induced by camptothecin analogs: the potential role in proteolytic activation of PKC delta and apoptosis. Proteomics 9:2064–2075

    Article  PubMed  CAS  Google Scholar 

  33. Kurdistani SK, Arizti P, Reimer CL et al (1998) Inhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53 and DNA damage. Cancer Res 58:4439–4444

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chuifeng Fan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fan, C., Yu, J., Liu, Y. et al. Increased NDRG1 Expression is Associated with Advanced T Stages and Poor Vascularization in Non-small Cell Lung Cancer. Pathol. Oncol. Res. 18, 549–556 (2012). https://doi.org/10.1007/s12253-010-9294-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-010-9294-2

Keywords

Navigation